Hematology NewsCAR T cells produce longest survival in low disease burden ALL patientsJanuary 31, 2018ALLLeukemia, Myelodysplasia, TransplantationImmunotherapy
Oncology PracticeCombination immunotherapy is active in dMMR/MSI-H metastatic colorectal cancerJanuary 26, 2018Immuno-oncologyGastroenterologyImmunotherapyGastrointestinal Cancer
Hematology NewsGene therapy moves from promise to realityJanuary 25, 2018Bleeding DisordersMultiple MyelomaImmunotherapy
Oncology PracticePhase 1 study: Human IL-10 plus checkpoint blockade looks promising in RCC, NSCLCJanuary 11, 2018Renal Cell CarcinomaLung CancerImmunotherapy
Hematology NewsUpdated ZUMA-1 data show durable CAR-T responses in B-cell lymphomasDecember 10, 2017Aggressive LymphomasCellular TherapyIndolent LymphomaLymphoma & Plasma Cell DisordersImmunotherapyImmuno-oncologyFollicular Lymphoma
Oncology PracticeDNA vaccine + PD-1 blockade shows promise in mCRPCDecember 9, 2017Immuno-oncologyImmunotherapyGenitourinary Cancer
Oncology PracticeNivolumab may extend survival in HCC patientsNovember 7, 2017ImmunotherapyGastroenterologyGI OncologyGastrointestinal Cancer
Oncology PracticeCheckmate 214: Upfront nivo/ipi bests TKI in advanced RCCSeptember 28, 2017Renal Cell CarcinomaImmunotherapyImmuno-oncology
Oncology PracticeCRP may predict survival after immunotherapy for lung cancerSeptember 20, 2017Immuno-oncologyLung CancerImmunotherapy
Oncology PracticeTocilizumab looks promising for corticosteroid refractory anti-PD-1-related adverse eventsSeptember 20, 2017Immuno-oncologyImmunotherapyLung CancerCellular Therapy
Oncology PracticeAdding T-vec might help surmount PD-1 resistance in melanomaSeptember 14, 2017Immuno-oncologyMelanomaImmunotherapy
The Journal of Community and Supportive OncologyAn ASCO 2017 recap: significant advances continueSeptember 8, 2017Breast CancerGenitourinary CancerGastroenterologyPatient & Survivor CareImmunotherapyGastrointestinal Cancer
Oncology PracticeAdverse effects of PD-1/PD-L1 inhibitors varied by tumor type in systematic reviewAugust 28, 2017Immuno-oncologyImmunotherapyMelanomaRenal Cell CarcinomaLung Cancer
Oncology PracticeFDA approves nivolumab for metastatic CRCAugust 2, 2017GastroenterologyImmuno-oncologyImmunotherapyGI OncologyGastrointestinal Cancer
Oncology PracticeNew SU2C translational team aims to apply CAR T-cell therapy to pancreatic cancerAugust 1, 2017Immuno-oncologyGastroenterologyImmunotherapyGastrointestinal Cancer
